Resumo

SANCHEZ LOPEZ, P; PRATS OLIVAN, P; APARICIO HERNANDEZ, R  e  GARCIA LUQUE, A. Positive assessment of drugs: December 2018, January and February 2019. Sanid. Mil. [online]. 2019, vol.75, n.2, pp.94-97. ISSN 1887-8571.  https://dx.doi.org/10.4321/s1887-85712019000100006.

The drugs assessed by the Spanish Agency for Medicines and Health Products or European Medicines Agency made public in December 2018, January and February of 2019 , and considered of interest to the healthcare professional, are reviewed. These are positive technical reports prior to the authorization and placing on the market of the product.

Palavras-chave : Andexanet Alfa (Ondexxya^®); Dacomitinib (Vizimpro^®); Fremanezumab (Ajovy^®); Lorlatinib (Lorviqua^®); Lusutrombopag (Lusutrombopag Shionogi^®); Naldemedina (Rizmoic^®); Pegvaliase (Palynziq^®); Risankizumab (Skyrizi^®); Ropeginterferon alfa 2-B (Besremi^®); Sotagliflozin (Zynquista^®); Treosulfan (Trecondi^®); Volanesorsen (Waylivra^®); Zanamivir (Dectova^®).

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )